CloserIQ

OCTOBER 16, 2019

In a hyper-competitive industry filled with giants, we need Millennials with superior sales acumen. The post Weekly Roundup – October 16, 2019 appeared first on CloserIQ Blog. ” Inspire Your Millennial Salespeople to Sell with Passion (Danita Bye of SalesGravy). “The world of sales is extremely stressful.

Sales 40

Sales Prospecting Competition Sales Strategy 40

CloserIQ

OCTOBER 23, 2019

Successful sales leaders are competitive, energetic, driven, passionate, communicative, inspiring, etc. The post Weekly Roundup – October 23, 2019 appeared first on CloserIQ. We’ve compiled some of our favorite reads to help you advance in your sales career and build top sales teams. Featured Article.

Sales Strategy 40

Sales Strategy Sales Management Recruitment 40

CloserIQ

OCTOBER 23, 2019

Successful sales leaders are competitive, energetic, driven, passionate, communicative, inspiring, etc. The post Weekly Roundup – October 23, 2019 appeared first on CloserIQ Blog. We’ve compiled some of our favorite reads to help you advance in your sales career and build top sales teams. Featured Article.

Sales Strategy 40

Sales Strategy Sales Management Recruitment 40

CloserIQ

FEBRUARY 1, 2019

“Despite the efforts of local colleges and universities, demand for tech workers has already outpaced supply, making competition fierce for the best software engineers, developers and data analysts, employers and educators said.” The post Weekly Roundup – Feb 4, 2019 appeared first on CloserIQ Blog.

Sales 45

Sales Training Prospecting Education 45

CloserIQ

FEBRUARY 1, 2019

“Despite the efforts of local colleges and universities, demand for tech workers has already outpaced supply, making competition fierce for the best software engineers, developers and data analysts, employers and educators said.” The post Weekly Roundup – Feb 1, 2019 appeared first on CloserIQ Blog.

Sales 40

Sales Training Prospecting Education 40

Pharmaceutical Technology

MARCH 8, 2023

This is the second time Lilly has significantly reduced the cost of its insulin, as in 2019 the company reduced the list price of Humalog by 50%. These two insulin therapies have been off patent for about a decade but have a list price of about $500 for a pack of five injection pens and currently have limited competition from biosimilars.

Competition 105

Competition Insurance Leads Marketing 105

World of DTC Marketing

MARCH 1, 2022

Hospitals, physicians, and clinical care made up more than half of the total healthcare spending in 2019. The lack of choice limits competition, which can drive prices higher. A KFF survey from March 2019 found that about one-fourth of U.S. Most Americans don’t have much of a choice for their insurance plan.

Insurance 154

Insurance Prescription Healthcare Healthcare 154

Referral MD

JULY 26, 2022

Since 2019, Press Ganey has gathered patient surveys to produce an annual report of what is driving them to pick one provider over another. And the findings are clear: Without a positive, up-to-date, and lively online presence, healthcare practices are falling behind and losing patients to the competition.

Healthcare 105

Healthcare Healthcare Healthcare Provider Competition 105

European Pharmaceutical Review

OCTOBER 5, 2022

The benefits of exposing students to the industry this way enables both parties to share knowledge, experience and provides students networking opportunities that can be difficult to obtain for such a competitive industry, said ABPI. It also found that The University of Bath, UK hosted the most industry placements: 61 in 2019 and 2022.

Pharma 87

Pharma Training Networking Doctors 87

pharmaphorum

NOVEMBER 17, 2022

The 2019 VPAS , just like its predecessor that was in place from 2014, has at its heart a payback mechanism. That is why companies who are members of the 2019 VPAS have collectively paid back almost £3 billion to the Department of Health and Social Care (DHSC) up to Quarter 2 of 2022. Predictable for government. Variable for companies.

Government 91

Government Sales Medicine Consulting 91

European Pharmaceutical Review

JANUARY 2, 2024

Pharma pushes for UK medicine scheme revision Drug pricing was considered as the most negative emerging regulatory and macroeconomic trend, impeding growth for the industry, based on GlobalData’s 2019, 2020, 2021, and 2022 industry outlooks.

Pharma 80

Pharma Medicine Government Marketing 80

World of DTC Marketing

MARCH 17, 2021

Pharma has gone to court again and again to delay generic competition of biologic drugs. One company AbbVie has used the courts to stop competition of its top drug Humira. For 2020, AbbVie’s handing its longtime CEO $24 million in total pay, up from 2019’s $21.6 In fact, Richard Gonzalez, C.E.O.

Pharma 186

Pharma Competition Prescription Doctors 186

PM360

FEBRUARY 1, 2024

The landscape is highly competitive with new prescription medications launching worldwide each year. Early shaping of the label during clinical trial design, risk mitigation, and avoiding approval delays are crucial for seizing a competitive advantage.

Biopharma 59

Biopharma Competition Prescription Education 59

pharmaphorum

NOVEMBER 16, 2022

Novartis completed the spin-out of Alcon in 2019, separating products like contact lenses and over-the-counter eyedrops from its prescription eye medicines, headed by age-related macular degeneration (AMD) blockbuster Lucentis (ranibizumab), which is partnered with Roche. billion in the first nine months of this year.

Sales 110

Sales Prescription Medicine Media 110

Healthcare Success

DECEMBER 6, 2022

In this blog, I share nine healthcare marketing trends you need to embrace in 2023 to remain competitive in today’s ever-changing healthcare marketplace. Competition from Retail and Telehealth Disruptors Continues to Intensif y. The COVID-19 pandemic supercharged a new type of competition for legacy healthcare organizations.

Healthcare 112

Healthcare Healthcare Marketing Competition 112

World of DTC Marketing

JUNE 1, 2021

Since that time, Biogen’s MS drugs have faced intense competition as MS patients continue to vent on social media that the Biogen drug has nasty side effects. After the CEO departed the sinking ship, new management pinned all their hopes on the Biogen drug for Alzheimer’s.

Side effects 187

Side effects FDA Patients Doctors 187

pharmaphorum

DECEMBER 15, 2022

of total sales – under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) introduced in 2019. Next year we must start again with a clean sheet of paper to agree on what an internationally competitive scheme looks like.” billion (around $4 billion) in revenue to the government – 26.5% VPAS tax on top. .

Pharma 69

Pharma Government Manufacturing Competition 69

Pharmaceutical Technology

DECEMBER 5, 2022

Overall, Aurinia’s Lupkynis is expected to face tough competition from Benlysta in LN, which received FDA approval in December 2020 and EMA approval in May 2021. Notably, Lupkynis is the first oral therapy approved by the US Food and Drug Administration (FDA) and EC for the treatment of active LN.

Food and Drug Administration 59

Food and Drug Administration Physicians Competition FDA 59

European Pharmaceutical Review

JUNE 8, 2023

A new report by the Association of the British Pharmaceutical Industry (ABPI) has identified the UK biopharma industry is increasingly seeking talent with artificial intelligence (AI) and data skills to maintain competitiveness as digital technology continues to drive innovation. This has spiked from 27 in 2019 to 225 in 2022.

Biopharma 83

Biopharma Government Training Education 83

pharmaphorum

JULY 18, 2022

The biotech – headquartered in the Netherlands but with R&D operations in Poland – said the EMA has accepted the marketing application for the biosimilar version of Tysabri’s active ingredient natalizumab, which will be sold by Novartis’ Sandoz unit if approved under the terms of a 2019 alliance.

Competition 52

Competition Marketing Sales Medicine 52

Integrity Solutions

MARCH 30, 2020

Those business plans were created in Q4 2019, a quarter that started with the continuation of the greatest period of economic expansion and stock market growth in history. What kinds of questions were company leaders asking during that last quarter of 2019 when those 2020 plans were being put together?

Sales 88

Sales Competition Ethics Marketing 88

Pharmaceutical Technology

SEPTEMBER 15, 2022

According to GlobalData’s report, Coronavirus Disease 2019 (Covid-19) Analyst Consensus Sales Analysis and Forecast, H1 2022 , Comirnaty is the leading prophylactic Covid-19 vaccine and recorded sales of $41.3bn in 2021. AbbVie reported a 22.7% Bristol Myers Squibb (BMS) documented a 9.1%

Sales 108

Sales Competition Pharmaceutical Pharmaceutical research 108

World of DTC Marketing

OCTOBER 5, 2021

Seventy-nine percent of Americans think the price of prescription drugs is “unreasonable,” according to a 2019 Kaiser Family Foundation poll , and about 9 in 10 say they support the idea of the government negotiating prices. Via Axios “The 10 highest-selling drugs in the U.S.

Pharma 241

Pharma Insurance Sales Government 241

pharmaphorum

NOVEMBER 10, 2022

Sales were around $140 million in 2019, and climbed to $165 million the following year, despite the impact of the pandemic. With finances tight, Clovis has deferred a $1.9 million interest payment on debt, and is now in a 30-day grace period that could lead to it being in default.

Competition 57

Competition Sales Leads Marketing 57

pharmaphorum

JANUARY 3, 2023

Side-effect data from the open-label studies was also encouraging, helping to downplay concerns abut evenamide’s cardiovascular and central nervous system safety that emerged in 2019. ” The new data could accelerate partnering efforts of the drug this year.

Side effects 98

Side effects Biopharma Patients Competition 98

Pharmaceutical Technology

JANUARY 10, 2023

Type 2 diabetes (T2D) is a crowded and competitive landscape with multiple “me-too,” generic and biosimilar drugs entering the market, with market growth primarily driven by an increasing prevalent population across nine major markets (9MM: US, France, Germany, Italy, Spain, UK, Japan, China, and India).

Marketing 52

Marketing Physicians Leads Competition 52

Clarivate

FEBRUARY 10, 2022

For this report on innovation in South and Southeast Asia, we analyzed patents filed from 2015 to 2019 by organizations headquartered in this region. To better understand the key players and the emerging, evolving trends in innovation, we looked across the South and Southeast Asia landscape in our latest report. Measuring innovation.

Government 52

Government Competition Engineering Manufacturing 52

Sales Talent

FEBRUARY 7, 2020

2019 Sales Hiring in Review. In our 2019 forecast we shared Former Federal Reserve Chairman Alan Greenspan’s observation of employment in the United States in late 2018. Things were even tighter at the end of 2019. in Dec 2019. in Dec 2019. According to the BLS, as of Oct 2019, there were 5.8M

Sales 52

Sales B2B Sales Recruitment Marketing 52

Legacy MEDSearch

NOVEMBER 23, 2022

“I am thankful for wonderful family, friends, colleagues, weather, and a competitive labor market!” . “I’m thankful for my little side kick!” ” – Joy Celebre, Practice Leader. ” – Chris Miclot, Partner and General Manager. ” – John White, Talent Sourcing Manager.

Recruitment 98

Recruitment Management Food Education 98

InCrowd

OCTOBER 25, 2022

Amazon Care was first launched in 2019 with the hopes of providing 24/7 telehealth services and in-person care to customers in the US. Walmart, CVS, and Walgreens are all bringing competition to the healthcare industry, creating many accessible and convenient ways for patients to receive care. Let us know on our social media pages!

Retail 52

Retail Healthcare Healthcare Physicians 52

European Pharmaceutical Review

JUNE 14, 2023

billion of GVA delivered by the life sciences industry in 2019. With manufacturing investment competition intensifying worldwide in recent years, the UK’s position as a manufacturing leader has declined. It provides almost 45 percent of the £36.9 This is compared to 13 percent (£4.8

Medicine 52

Medicine Manufacturing Government Competition 52

Contrarian Sales Techniques

FEBRUARY 1, 2023

This is what sets your product apart from the competition and gives your customers a reason to choose your product over others. have increased by 2% from 2018 to 2019, reaching over $18 billion in 2019. The dairy industry is a large and growing market, with milk being one of the most consumed and versatile products worldwide.

Sales Strategy 52

Sales Strategy Sales Sales pitches Prospecting 52

Clarify Health

SEPTEMBER 23, 2022

Here’s a recap on the current market challenges that leading health systems are facing and the effective strategies they are using today in order to stay ahead of tomorrow’s competition: In today’s ever-shifting consumer landscape, it’s crucial to understand the needs of your market(s) if you want to attract and retain patients.

Patients 52

Patients Recruitment Competition Physicians 52

pharmaphorum

SEPTEMBER 11, 2022

Bristol-Myers Squibb’s deucravacitinib– one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe plaque psoriasis. billion oral psoriasis therapy Otezla (apremilast). Otezla was acquired by Amgen for $13.4

FDA 52

FDA Marketing Sales Patients 52

pharmaphorum

JULY 12, 2022

However, with lower-cost generics of Endo’s drug now reaching the market, Giapreza is facing even more competitive pressure. La Jolla has been able to keep its cash reserves fairly constant at around $46 million each quarter, but there’s no disguising that it has been struggling.

Pharma 52

Pharma Sales Marketing Competition 52

pharmaphorum

JULY 15, 2022

” KW-6356 is a follow-up to Kyowa Kirin’s first-generation adenosine A2 antagonist Nourianz/Nouriast (istradefylline), which finally claimed FDA approval in 2019 as an add-on to levodopa in Parkinson’s after more than two decades of R&D and has been available in Japan since 2013. billion yen (around $68 million).

Competition 57

Competition Marketing Medicine FDA 57

pharmaphorum

JANUARY 24, 2023

In this final instalment of IQVIA EMEA Thought Leadership’s Nine for 2023 three-part series, focusing on issues that will change the direction of healthcare and the pharmaceutical industry this year, three key competitive issues for pharmaceutical companies in 2023 are assessed.

Medicine 82

Medicine Healthcare Healthcare Pharma 82